Pharmaceutical EthicsSam Salek, Andrew Edgar Wiley, 11. okt. 2002 - 216 sider Pharmaceutical Ethics is an important text, which aims to provide the ethical guidelines much needed by the pharmaceutical industry. By focusing on many of the central issues such as the ethical aspects of clinical trials, informed consent, physician or patient choice and pharmaceutical advertising, this text will provide very good coverage of an area which perhaps still lacks coherent instruction. * Covers ethical issues involved in the testing and use of pharmaceuticals on human beings * Investigates issues such as whether choice of drug should lie with the physician or the patient * Looks at a wide variety of subjects connected with pharmaceutical ethics. * Focuses specifically on the issues surrounding the pharmaceutical industry, not medicine in general. * Fulfils an important need in the Pharmaceutical Industry. |
Fra bogen
Resultater 1-3 af 26
Side 47
... economic models , al- though how the mega - funding of major new medicines developments is to be achieved otherwise is hard to see . It is often judged that medicine is a special area to which society should not apply normal economic ...
... economic models , al- though how the mega - funding of major new medicines developments is to be achieved otherwise is hard to see . It is often judged that medicine is a special area to which society should not apply normal economic ...
Side 114
... economic burden . Studies of emergency departments ( EDs ) have shown that between 2.9 and 3.9 % of ED admissions are directly related to DRPS ( 9 ) . Dennehy et al . estimated total annual costs of these DRP - related admissions at US ...
... economic burden . Studies of emergency departments ( EDs ) have shown that between 2.9 and 3.9 % of ED admissions are directly related to DRPS ( 9 ) . Dennehy et al . estimated total annual costs of these DRP - related admissions at US ...
Side 115
... economic , and humanistic ) ( Table 9.1 , Scenario 1 ) . A major ethical issue surfaces when one or more of these outcomes does not improve , but rather worsens as a result of treatment ( Table 9.1 , Scenarios 2–6 ) . For example ...
... economic , and humanistic ) ( Table 9.1 , Scenario 1 ) . A major ethical issue surfaces when one or more of these outcomes does not improve , but rather worsens as a result of treatment ( Table 9.1 , Scenarios 2–6 ) . For example ...
Indhold
The Basis of Ethics | 1 |
Principles of Ethics Focusing on the Patient | 13 |
Ethical Rationalism Applied to Pharmaceuticals | 27 |
Copyright | |
8 andre sektioner vises ikke
Andre udgaver - Se alle
Almindelige termer og sætninger
2002 John Wiley acceptable active adverse drug reactions advertising of medicines analysis antidepressant approach assessment autonomy behaviour benefit biomedical Bootman cancer choice clinical practice clinical trials cognitive condition cost culture debate decision decision-making Declaration of Helsinki depression and anxiety discourse ethics discussion disease doctor DRPs drug-related morbidity economic effective efficacy emotional ethics committee evaluation example factors gastro-oesophageal reflux disease guidelines H2 antagonists health professionals healthcare Hippocratic Oath hospital human individual informed consent involved medical ethics medical paternalism ment morbidity and mortality myocardial infarction NSAIDs Nuremberg Code participation person perspective Pharm Pharmaceutical Ethics pharmaceutical industry pharmacist pharmacoeconomic pharmacological pharmacy physician placebo potential prescribing prescription principles problems protocol Psychiatry psychotropic question rational reason requires responsibility result risk Salek scientific self-harmer social society strategies studies symptoms treat treatment unethical values